L
Leif Bertilsson
Researcher at Karolinska University Hospital
Publications - 321
Citations - 24620
Leif Bertilsson is an academic researcher from Karolinska University Hospital. The author has contributed to research in topics: Debrisoquine & Debrisoquin. The author has an hindex of 87, co-authored 321 publications receiving 23933 citations. Previous affiliations of Leif Bertilsson include Astra & University of Oulu.
Papers
More filters
Journal ArticleDOI
Genetic analysis of the CYP2D locus in relation to debrisoquine hydroxylation capacity in Korean, Japanese and Chinese subjects.
Marja-Liisa Dahl,Q. Y. Yue,Hyung-Keun Roh,Inger Johansson,Juliette Säwe,Folke Sjöqvist,Leif Bertilsson +6 more
TL;DR: The present pilot study revealed major similarities in the polymorphic CYP2D locus between Korean, Japanese and Chinese populations.
Journal ArticleDOI
Pharmacogenetics of antidepressants: clinical aspects
TL;DR: Genotyping compared with phenotyping is that the former may be performed in blood samples from patients irrespective of treatment, and the former has a major advantage of genotyping than the latter.
Journal ArticleDOI
Steady-state concentrations of imipramine and its metabolites in relation to the sparteine/debrisoquine polymorphism
TL;DR: Treatment with imipramine inhibited metabolism of both sparteine and debrisoquine (MR values about doubled), but did not affect the interpatient correlations.
Journal ArticleDOI
Haloperidol disposition is dependent on the debrisoquine hydroxylation phenotype: increased plasma levels of the reduced metabolite in poor metabolizers.
TL;DR: The plasma levels of the reduced metabolite of haloperidol, after a single 2- or 4-mg oral dose of the parent drug, are significantly higher in PM than in EM of debrisoquine.
Journal ArticleDOI
Genetic analysis of the interethnic difference between Chinese and Caucasians in the polymorphic metabolism of debrisoquine and codeine.
Inger Johansson,Q. Y. Yue,Marja-Liisa Dahl,Markus H. Heim,Juliette Säwe,Leif Bertilsson,U. A. Meyer,Folke Sjöqvist,Magnus Ingelman-Sundberg +8 more
TL;DR: The results provide a molecular explanation of the interethnic difference in the metabolism of drugs affected by the debrisoquine hydroxylation polymorphism.